Stefan Röever

gBox Inc. operates an online music store. It creates a platform, portal and tools to interact on social networking sites and internet venues to buy and receive gifts. The company was founded in 2007 and is headquartered in Cupertino, CA.

Peptilogics, Inc. operates as an early-stage biotechnology company, that develops a new class of antibiotics with a novel mechanism of action derived from their eCAP (engineered cationic antibiotic peptide) platform for the treatment of multidrug-resistant infections. Its platform has the potential to produce antibiotics with broad-spectrum activity with low risk of generating resistance, due to the unique mechanism of action involving the targeted disruption of bacterial membranes. The company was founded by Jonathan Steckbeck and is headquartered in Pittsburgh, PA.

Genia Technologies, Inc. develops DNA sequencing platforms. Its nanopore-based platform allows for single molecule, electrical real-time analysis without the need for complicated optics, labels, and amplification, or fluidics. The firm's sequencing platform enables the use of molecular diagnostics in everyday clinical care. The company was founded by Roger Chen, Stefan Roever, Pratima Rao, and Randy Davis in March 2009 and is headquartered in Santa Clara, California

Peptilogics, Inc. operates as an early-stage biotechnology company, that develops a new class of antibiotics with a novel mechanism of action derived from their eCAP (engineered cationic antibiotic peptide) platform for the treatment of multidrug-resistant infections. Its platform has the potential to produce antibiotics with broad-spectrum activity with low risk of generating resistance, due to the unique mechanism of action involving the targeted disruption of bacterial membranes. The company was founded by Jonathan Steckbeck and is headquartered in Pittsburgh, PA.

FDGS Group LLC operates as a holding company. It provides transaction processing systems, software, and professional services to business, mobile, and government markets. It also offers electronic invoice and payment solutions, and electronic tax payment processing services. The company was founded in 2000 and is headquartered in Napa, CA.

gBox Inc. operates an online music store. It creates a platform, portal and tools to interact on social networking sites and internet venues to buy and receive gifts. The company was founded in 2007 and is headquartered in Cupertino, CA.

Genia Technologies, Inc. develops DNA sequencing platforms. Its nanopore-based platform allows for single molecule, electrical real-time analysis without the need for complicated optics, labels, and amplification, or fluidics. The firm's sequencing platform enables the use of molecular diagnostics in everyday clinical care. The company was founded by Roger Chen, Stefan Roever, Pratima Rao, and Randy Davis in March 2009 and is headquartered in Santa Clara, California

Peptilogics, Inc. operates as an early-stage biotechnology company, that develops a new class of antibiotics with a novel mechanism of action derived from their eCAP (engineered cationic antibiotic peptide) platform for the treatment of multidrug-resistant infections. Its platform has the potential to produce antibiotics with broad-spectrum activity with low risk of generating resistance, due to the unique mechanism of action involving the targeted disruption of bacterial membranes. The company was founded by Jonathan Steckbeck and is headquartered in Pittsburgh, PA.

Peptilogics, Inc. operates as an early-stage biotechnology company, that develops a new class of antibiotics with a novel mechanism of action derived from their eCAP (engineered cationic antibiotic peptide) platform for the treatment of multidrug-resistant infections. Its platform has the potential to produce antibiotics with broad-spectrum activity with low risk of generating resistance, due to the unique mechanism of action involving the targeted disruption of bacterial membranes. The company was founded by Jonathan Steckbeck and is headquartered in Pittsburgh, PA.

Peptilogics, Inc. operates as an early-stage biotechnology company, that develops a new class of antibiotics with a novel mechanism of action derived from their eCAP (engineered cationic antibiotic peptide) platform for the treatment of multidrug-resistant infections. Its platform has the potential to produce antibiotics with broad-spectrum activity with low risk of generating resistance, due to the unique mechanism of action involving the targeted disruption of bacterial membranes. The company was founded by Jonathan Steckbeck and is headquartered in Pittsburgh, PA.